“…We have previously characterized SLI in rat hypothalamus and identified three forms of immunoreactivity: one with a molecular weight of 15,000, comprising -5% of total SLI (15,000-mol-wt SLI); a second form of Mr = 3,000 (3,000-mol-wt SLI) accounting for -25% of total SLI; and a third, dominant form of Mr = 1,600 (-70% of total SLI), which corresponds to SRIF (6). Recent amino acid analyses have established the identity of 1,600-mol-wt SLI with SRIF (16) and of 3,000-mol-wt SLI with that of somatostatin-28 (S-28) (17), a biologically active 14 amino acid N-terminally extended form of SRIF isolated from mammalian hypothalamus and intestine (18)(19)(20). Our earlier investigations on the processing of 15,000-mol-wt SLI and S-28 by hypothalamic enzymes support a possible role for both peptides as precursors for S-14 (21,22).…”